Superseded public profile

U.S. label recordMetabolic

Superseded · version 2: Liraglutide

A GLP-1 receptor agonist. This profile cites a U.S. label record.

This is preserved historical wording.
It is no longer the current profile. Read the current profile and its correction notice.
Update · July 27, 2026

We rewrote the profile summary to describe the cited public record more directly. The cited sources and status did not change. 1

What this version reported

The cited DailyMed label identifies Liraglutide and contains the product's official indications and warnings. This profile links to the label without restating it as medical guidance.

Organizations named in cited records:
  • U.S. National Library of Medicine

Sources for this version

  1. 1
    Liraglutide injection, solution · SPL version 6 · published 2026-07-14 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026